Expands Access with Full US Commercial Release of CAP24
other announcement

Saluda Medical, Inc. is a medical technology company focused on developing and commercializing innovative solutions for patients suffering from chronic pain. Their primary focus is on neurostimulation therapies, aiming to provide more effective and personalized pain relief. Saluda's technology seeks to disrupt the pain management market by removing guesswork and tailoring treatment to individual patient needs.
Saluda Medical (ASX:SLD) has 0.11% of its shares on issue reported as short positions as of 5 Oct 2026, or about 274,301 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has risen 0.06 percentage points. SLD is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Latest articles and price-sensitive announcements with AI sentiment classification.
other announcement
other announcement
Why Saluda Medical (ASX:SLD) Could Be an ASX Healthcare Stock to Watch This September Kalkine
other announcement
other announcement
Saluda Medical (ASX: SLD) — Why This Neuromodulation Company Is in the Spotlight Kalkine
Saluda Medical (ASX:SLD) Eases As Investors Lock In Gains After Results Rally Kalkine
Saluda Medical (ASX:SLD) beats FY26 as CAP24 door opens Stocks Down Under
other announcement
Saluda Medical (ASX: SLD): Healthcare Stock Slips as Sector Faces Selling Pressure Kalkine
Saluda Medical (ASX: SLD) Declines as Investors Monitor US Commercial Expansion Kalkine
other announcement
Saluda Medical (ASX:SLD) Shares Fall as Emerging Healthcare Companies Face Selling Pressure Kalkine
other announcement
other announcement
other announcement
other announcement
guidance announcement
other announcement